Overview

Effect of Riociguat on Bone Metabolism

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Investigation of the effect of Riociguat, administered as 2.5 mg IR-tablets TID over 14 days, on bone metabolism.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Riociguat